Direct-to-Consumer Genetic Testing Market Worth $7.19
The direct-to-consumer genetic testing market is growing at a CAGR of 19.6% from 2022 to 2030....
Stay updated with breaking news from Genetics Inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The direct-to-consumer genetic testing market is growing at a CAGR of 19.6% from 2022 to 2030....
Data Bridge Market Research conducted a recent market intelligence study, thoroughly analysing the Prostate Cancer Antigen 3 (PCA3) Test Market. The newly published report employs an appealing layout that presents essential data using visually engaging tables, graphs, charts, and figures.The Prostate Cancer Antigen...
/PRNewswire/ -- The "Rare Disease Genetic Testing Market - A Global and Regional Analysis: Focus on Disease Type, Offering, Specialty Type, Sample Type, Trait...
Myriad Genetics, Inc. (NASDAQ:MYGN – Get Free Report) was down 4% during mid-day trading on Friday . The company traded as low as $15.99 and last traded at $16.12. Approximately 265,475 shares changed hands during trading, a decline of 53% from the average daily volume of 562,167 shares. The stock had previously closed at $16.79. […]
SALT LAKE CITY, Sept. 28, 2023 -- Myriad Genetics, Inc. , a leader in genetic testing and precision medicine, today announced results from a nationwide survey revealing breast density and family...